Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-27

Clinical Trial Update: Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings

View source ↗

Summary

Observational study assessing Etanercept (Enbrel) for plaque-type psoriasis in usual care settings has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Psoriasis | Status: COMPLETED | Results posted: 2015-07-27